The function of the Access & Product Management Advisory Committee (APMAC) is to advise MMV's Access team on appropriate strategies to achieve its goals.

The APMAC is composed of between 8 and 16 members, with appointments staggered so as to provide rotating membership.

The members of the APMAC come from both industry and academia and cover the full range of expertise required to achieve access objectives.

APMAC Members

Dr Susanna Hausmann-Muela, Chief Program Officer, Botnar Foundation, Switzerland

Dr Elizabeth Juma, WHO Inter-country Support Team for Eastern and Southern Africa 

Dr Corine Karema, Swiss TPHI, Switzerland; Malaria Expert on Global Fund TRP; former Dir NMCP, Rwanda

Ms Maeve Magner, MBA, Supply Chain Expert, USA | Ireland

Dr Wilfrid Mbacham, Fellow CAS / AAS, Chair Dept of Physiology and Biochemistry, Univ of Yaoundé, Cameroon

Dr Kamini Mendis, Independent Consultant in Malaria and Tropical Medicine, Sri Lanka

Dr Frank O Richards Jr, MD Director, River Blindness Elimination Program, Lymphatic Filariasis Elimination Program, and Schistosomiasis Control Program at The Carter Center, Atlanta, GA, USA

Dr Martin De Smet, Coordinator of the Malaria Working Group of MSF (Médecins Sans Frontières)